Nisa Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.69M | Buy |
8,242
+87
| +1% | +$28.4K | 0.01% | 558 |
|
|
2025
Q1 | $2.2M | Sell |
8,155
-5,162
| -39% | -$1.39M | 0.01% | 616 |
|
|
2024
Q4 | $3.13M | Buy |
13,317
+1,789
| +16% | +$421K | 0.01% | 557 |
|
|
2024
Q3 | $3.17M | Buy |
11,528
+3,373
| +41% | +$928K | 0.02% | 532 |
|
|
2024
Q2 | $1.98M | Hold |
8,155
| – | – | 0.01% | 699 |
|
|
2024
Q1 | $1.22M | Hold |
8,155
| – | – | 0.01% | 817 |
|
|
2023
Q4 | $1.56M | Hold |
8,155
| – | – | 0.01% | 729 |
|
|
2023
Q3 | $1.44M | Hold |
8,155
| – | – | 0.01% | 760 |
|
|
2023
Q2 | $1.55M | Sell |
8,155
-2,200
| -21% | -$418K | 0.01% | 745 |
|
|
2023
Q1 | $2.07M | Sell |
10,355
-25
| -0.2% | -$5.01K | 0.02% | 659 |
|
|
2022
Q4 | $2.47M | Hold |
10,380
| – | – | 0.02% | 671 |
|
|
2022
Q3 | $2.09M | Sell |
10,380
-353
| -3% | -$70.9K | 0.02% | 619 |
|
|
2022
Q2 | $1.57M | Buy |
10,733
+2,950
| +38% | +$430K | 0.01% | 699 |
|
|
2022
Q1 | $1.27M | Sell |
7,783
-984
| -11% | -$161K | 0.01% | 790 |
|
|
2021
Q4 | $1.21M | Sell |
8,767
-21,760
| -71% | -$2.99M | 0.01% | 782 |
|
|
2021
Q3 | $5.76K | Buy |
30,527
+17,415
| +133% | +$3.29K | 0.04% | 407 |
|
|
2021
Q2 | $2.22K | Sell |
13,112
-17,900
| -58% | -$3.04K | 0.01% | 689 |
|
|
2021
Q1 | $4.38K | Buy |
31,012
+15,700
| +103% | +$2.22K | 0.03% | 487 |
|
|
2020
Q4 | $1.99M | Buy |
15,312
+2,870
| +23% | +$373K | 0.01% | 696 |
|
|
2020
Q3 | $1.81M | Sell |
12,442
-4,416
| -26% | -$643K | 0.01% | 627 |
|
|
2020
Q2 | $2.5M | Buy |
16,858
+4,378
| +35% | +$648K | 0.02% | 528 |
|
|
2020
Q1 | $1.36M | Buy |
12,480
+2,000
| +19% | +$218K | 0.02% | 625 |
|
|
2019
Q4 | $1.21M | Sell |
10,480
-30,000
| -74% | -$3.46M | 0.01% | 821 |
|
|
2019
Q3 | $3.26M | Buy |
40,480
+33,132
| +451% | +$2.66M | 0.03% | 487 |
|
|
2019
Q2 | $533K | Sell |
7,348
-4,335
| -37% | -$314K | 0.01% | 1054 |
|
|
2019
Q1 | $1.09M | Buy |
11,683
+2,259
| +24% | +$211K | 0.01% | 819 |
|
|
2018
Q4 | $687K | Sell |
9,424
-400
| -4% | -$29.2K | 0.01% | 903 |
|
|
2018
Q3 | $860K | Buy |
9,824
+2,174
| +28% | +$190K | 0.01% | 936 |
|
|
2018
Q2 | $753K | Buy |
7,650
+6,150
| +410% | +$605K | 0.01% | 937 |
|
|
2018
Q1 | $179K | Sell |
1,500
-5,700
| -79% | -$680K | ﹤0.01% | 1263 |
|
|
2017
Q4 | $915K | Buy |
7,200
+700
| +11% | +$89K | 0.01% | 861 |
|
|
2017
Q3 | $764K | Hold |
6,500
| – | – | 0.01% | 909 |
|
|
2017
Q2 | $447K | Buy |
6,500
+1,500
| +30% | +$103K | 0.01% | 1054 |
|
|
2017
Q1 | $256K | Buy |
+5,000
| New | +$256K | ﹤0.01% | 1193 |
|
|
2016
Q4 | – | Sell |
-2,300
| Closed | -$156K | – | 1875 |
|
|
2016
Q3 | $156K | Hold |
2,300
| – | – | ﹤0.01% | 1269 |
|
|
2016
Q2 | $128K | Buy |
+2,300
| New | +$128K | ﹤0.01% | 1292 |
|